HHS says that if the Substance Abuse and Mental Health Services Administration is unable to complete a rulemaking that allows providers in opioid treatment programs to continue to initiate buprenorphine following a telehealth visit before the May 11 end of the public health emergency, SAMHSA will enact interim measures to bridge any gap that may result after the PHE ends. SAMHSA proposed the rule, Medications for the Treatment of Opioid Use Disorder, in December, but it plans to propose an...